Shon Chakrabarti MD Mph
About Shon Chakrabarti MD Mph
Shon Chakrabarti, MD, MPH, serves as the Chief Medical Officer at LimFlow, bringing extensive experience in clinical practice and medical technology innovation. He has held various leadership roles in prominent medical organizations, focusing on addressing unmet clinical needs through disruptive technology.
Current Role at Inari Medical
Shon Chakrabarti serves as the Chief Medical Officer at Inari Medical, a position he has held since 2024. In this role, he focuses on advancing medical technologies and improving patient outcomes. His leadership is instrumental in guiding the company's strategic direction and clinical initiatives.
Previous Experience at Abiomed
Prior to his current role, Chakrabarti worked at Abiomed, where he held two key positions. He served as the Director of Clinical Research and Medical Affairs from 2020 to 2021 and as the Medical Director from 2018 to 2020. His work involved overseeing clinical research initiatives and medical affairs strategies.
Educational Background
Chakrabarti holds a Master of Public Health (M.P.H.) from Harvard T.H. Chan School of Public Health, where he studied Clinical Effectiveness. He also earned a Doctor of Medicine (M.D.) from Wayne State University School of Medicine and a Bachelor of Science (BS) in Chemical Engineering from the University of Michigan.
Medical and Engineering Expertise
Chakrabarti combines a background in engineering and medicine, with expertise in Chemical Engineering and Interventional Cardiology. This unique combination allows him to bridge the gap between patient care and technological advancements, focusing on addressing unmet clinical needs through innovative solutions.
Career in Clinical Practice and Innovation
Chakrabarti has a diverse career that includes clinical practice and medical technology innovation. He has held various positions in prestigious institutions, including Harvard Medical School as a Cardiovascular Disease Fellow and Chesapeake Regional Healthcare as Vice Chief of Medicine. His commitment lies in improving patient outcomes through the integration of advanced medical technologies.